GW438014A 10mg 10mg | Purity Not Available
Adooq Bioscience
GW438014A is a potent and selective neuropeptide Y Y5 receptor antagonist.
More Information Supplier PageGW438014A is a potent and selective neuropeptide Y Y5 receptor antagonist.
More Information Supplier PageGR203040 is a novel, potent and selective non-peptide tachykinin NK1 receptor antagonist.
More Information Supplier PageGR203040 is a novel, potent and selective non-peptide tachykinin NK1 receptor antagonist.
More Information Supplier PageGR203040 is a novel, potent and selective non-peptide tachykinin NK1 receptor antagonist.
More Information Supplier PageFlibanserin is a new drug being investigated for the prevention of HSDD in woman.
More Information Supplier PageFlibanserin is a new drug being investigated for the prevention of HSDD in woman.
More Information Supplier PageFlibanserin is a new drug being investigated for the prevention of HSDD in woman.
More Information Supplier PageA 841720 is a potent, non-competitive mGluR-1 antagonist that displays 34-fold selectivity over mGluR-5 (IC50 values are 10 and 342 nM respectively).
More Information Supplier PageTAK-779 is a novel, potent and selective small-molecule antagonists of CCR5 with the IC50 value of 1.4nM in binding assay.
More Information Supplier PageTAK-779 is a novel, potent and selective small-molecule antagonists of CCR5 with the IC50 value of 1.4nM in binding assay.
More Information Supplier Page